Molecular Partners AG (MOLN.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: -55.55%; 2025 (actual)
ROA: -47.31%; 2025 (actual)
Gross Margin: -
Net Margin: -
Total Assets: CHF 102,107.00K; 2025 (actual)
Net Income: -CHF 61,651.00K; 2025 (actual)
Valuation: CHF 129,663.23K; 2025 (actual)
Stock Price: CHF 3.39; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-55.55%	-124.56%	507.2%	83.53%	45.51%	31.28%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	-47.31%	-86.51%	-622.21%	298.9%	298.91%	298.9%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Total Assets	CHF 102,107.00K	CHF 40,444.68K	-

Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Molecular Partners AG? It covers the balance sheet, income statement and Equlion model projections.

Net Income	-CHF 61,651.00K	-CHF 61,662.32K	-CHF 61,655.17K	-CHF 61,653.20K	-CHF 61,655.29K	-CHF 61,653.13K
Sector average	CHF 509,037.80K	CHF 497,738.03K	CHF 567,206.48K	CHF 655,953.18K	CHF 738,044.20K	CHF 795,142.15K

Valuation	CHF 129,663.23K	CHF 129,687.03K	CHF 129,671.99K	CHF 129,667.85K	CHF 129,672.25K	CHF 129,667.72K
Sector average	CHF 12,182,569.70K	CHF 13,169,956.24K	CHF 13,319,586.58K	CHF 13,502,659.68K	CHF 13,728,881.51K	CHF 13,908,079.25K

Stock Price	CHF 3.39	CHF 3.39	CHF 3.39	CHF 3.39	CHF 3.39	CHF 3.39
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32